Citi upgrades Haemonetics to Buy, raises price target to $123

September 17, 2026 5:01 AM EDT Send to a Friend
(Updated - September 17, 2026 5:02 AM EDT)

Citi analyst Joanne Wuensch upgraded Haemonetics (NYSE: HAE) from Neutral to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login